CDKN2B and myelodysplastic syndrome: Compared with patients presenting normal RPL23 expression levels, higher-risk MDS patients with increased RPL23 expression demonstrated decreased Miz-1 expression, which resulted in suppression of Miz-1-induced p15Ink4b and p21Cip1 expression in their BM haematopoietic cells.